🇺🇸 FDA
Pipeline program

TARA-002

TARA-002-101 (Phase 1a)

Phase 2 mab active

Quick answer

TARA-002 for Non-muscle Invasive Bladder Cancer is a Phase 2 program (mab) at Protara Therapeutics with 3 ClinicalTrials.gov record(s).

Program details

Company
Protara Therapeutics
Indication
Non-muscle Invasive Bladder Cancer
Phase
Phase 2
Modality
mab
Status
active

Clinical trials